论文部分内容阅读
目的探讨BIPAP呼吸机治疗慢性肺源性心脏病合并II型呼吸衰竭的临床疗效。方法选择2009年5月至2010年6月我院收治的慢性肺源性心脏病并发Ⅱ型呼吸衰竭患者32例,随机将患者平分为治疗组和对照组。两组患者经明确诊断后均行常规治疗,治疗组加用BIPAP呼吸机治疗。结果与对照组相比,治疗组患者治疗后PaO2、pH、SaO2明显提高,而PaCO2明显降低,差异均有统计学意义(P<0.05)。结论采BIPAP呼吸机治疗慢性肺源性心脏病合并II型呼吸衰竭疗效确切,效果显著,且创伤性小,值得临床推广。
Objective To investigate the clinical efficacy of BIPAP ventilator in the treatment of chronic pulmonary heart disease complicated with type II respiratory failure. Methods From May 2009 to June 2010, 32 patients with chronic pulmonary heart disease complicated with type Ⅱ respiratory failure admitted to our hospital were randomly divided into treatment group and control group. Two groups of patients were diagnosed after conventional treatment, the treatment group plus BIPAP ventilator treatment. Results Compared with the control group, PaO2, pH, SaO2 and PaCO2 were significantly decreased in the treatment group after treatment (P <0.05). Conclusion BIPAP ventilator for treatment of chronic cor pulmonale complicated with type II respiratory failure has definite effect, remarkable curative effect and less invasiveness, which deserves clinical promotion.